A new study in collaboration with Universitätsklinikum Hamburg-Eppendorf (UKE) and CTC North GmbH & Co. KG has been approved by the German Gemeinsamer Bundesausschuss (G-BA) on December 4. The G-BA has commissioned the UKE to research the benefits of allogeneic stem cell transplantation to treat multiple myeloma in relapsed/progressive patients. The project is led by principal investigator Prof. Dr. Nicolaus Kröger of UKE. Staburo GmbH is responsible for the statistical analysis. More information can be found in the press release of the G-BA (https://www.g-ba.de/presse/pressemitteilungen/917/).
New publication in BMC Bioinformatics: shadowVIMP: permutation-based multiple testing-controlled variable selection
We’re pleased to share that our methodological work on variable selection with random forests has now been published in BMC Bioinformatics. The paper introduces shadowVIMP, a novel variable selection method based on random forest importance measures and...
